Friday, November 6, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Earnings callNasdaq· November 27, 2025

NICE (NICE) Q3 2025 Earnings Call Transcript

View original at nasdaq.com
“Financial Crime & Compliance Segment Revenue -- $119 million, 16% of total revenue, up 7% year-over-year.”
Verbatim excerpt from the source · Nasdaq · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Operating margin slight contraction expected due to Cognigy integration, versus prior expectation of +50 bps expansion

    80% confidence

  • LiveVox stabilized after elevated churn earlier in 2025, forecasting ongoing cloud revenue growth

    80% confidence

  • Higher win rate versus key CX competitors in Q3 2025

    80% confidence

  • Gross margin contraction from 71.7% to 69.9% attributed to global cloud expansion and international infrastructure investments

    80% confidence

  • Combination of CCaaS + conversational AI is unique in market as differentiation

    80% confidence

  • AI capabilities included in every new 7-figure CX deal in Q3 2025

    80% confidence

  • Purpose-built AI for CX differentiates from general-purpose LLMs through ownership of engagement data across billions of interactions

    80% confidence

  • International markets underpenetrated for cloud adoption representing continued opportunity

    80% confidence

  • Cloud NRR expected to inflect positively in coming quarters as backlog is building

    80% confidence

  • Autopilot and Copilot bookings more than tripled in Q3 2025

    80% confidence

  • Cognigy integration capabilities already completed with more underway

    80% confidence

  • The symbiosis of CX engagement data dynamically informing AI agent conversations and actions, all happening as a part of a single unified platform is at the core of differentiation

    80% confidence

  • Strong demand for CX AI transformation driven by proven ROI unlike other AI segments

    80% confidence

  • Actimize maintains market leader position with high retention rates and no customer losses post-implementation

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Oncology Data Season and Biotech Capital Allocation: ESMO Readouts, Ivonescimab PDUFA, and Diverging Corporate Moves
Late-2026 biotech is driven by a dense catalyst calendar. ESMO 2026 delivers data from ivonescimab, Enhertu, R-DXd and bemarituzumab, and the FDA has set a 14 Nov PDUFA date for the ivonescimab BLA. Capital allocation is diverging. Krystal Biotech authorized a $400M buyback while lowering FY2026 spend guidance and pushing milestones into 2027. Spago is moving to delist from Nasdaq First North. The facts are clinical and corporate events, not AI or fintech, so the finance angle is limited to capital markets (buybacks, guidance, delistings, regulatory timelines).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,549 source documents archived
Query this data → isubstrate.com
NICE (NICE) Q3 2025 Earnings Call Transcript — Source | Via News | Via News